Dr. John Norman is a partner and litigator in Gowling WLG’s Ottawa office and a member of its Intellectual Property Group. John represents a wide range of clients including leading Canadian and international pharmaceutical, biotechnology, biologic and technology companies. He primarily focuses on pharmaceutical lifecycle management helping clients build robust patent portfolios and develop litigation strategies that can withstand the rigours of litigation by multiple challengers. With a PhD in Biochemistry, John brings deep scientific insight to complex, multi-patent litigation involving small molecules, vaccines, and biologics. He advises on pharmaceutical regulation and patent litigation, including patent infringement actions, patent impeachment actions and proceedings under thePatented Medicine (Notice of Compliance) Regulations and before the Patented Medicine Prices Review Board. John also appears before the Federal Court of Canada, the Federal Court of Appeal and the SCC. He served on the board of directors of BIOTECanada for 10 years and is a frequent speaker and writer on pharmaceutical and tech patent litigation matters. John has been recognized in Chambers Global, Chambers Canada, IAM Patent 1000 and Managing Intellectual Property: IP Stars among other publications.
